etodolac 400 mg
INDICATIONS AND USAGE Carefully consider the potential benefits and risks of etodolac extended-release tablets and other treatment options before deciding to use etodolac extended-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac extended-release tablets are indicated:
zydus pharmaceuticals usa inc.
OVAL BROWN 271
271 OVAL BROWN
Related Pills
24 HR etodolac 400 MG Extended Release Oral Tablet
zydus pharmaceuticals usa inc.
etodolac 500 mg
Zydus Pharmaceuticals (USA) Inc.
SMX 400 MG TMP 80 MG Oral Tablet
Amneal Pharmaceuticals
Oxybutynin Chloride 24 HR Oxybutynin chloride 10 MG Extended Release Oral Tablet
Aphena Pharma Solutions - Tennessee, Inc.
Sulfamethoxazole 400 MG Trimethoprim 80 MG Oral Tablet
Amneal Pharmaceuticals of New York, LLC
pioglitazone 15 MG Oral Tablet
Teva Pharmaceuticals USA, Inc.
Diazepam 2 MG Oral Tablet
Mylan Pharmaceuticals Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
ETODOLAC Extended-Release Tablets USP, 400 mg are orange-colored, oval-shaped, beveled edged, film-coated tablets, debossed with "271" on one side and plain on other side and are supplied as follows: NDC 68382-271-14 in bottles of 60 tablets with child–resistant closure NDC 68382-271-01 in bottles of 100 tablets NDC 68382-271-05 in bottles of 500 tablets NDC 68382-271-10 in bottles of 1,000 tablets NDC 68382-271-77 in unit-dose blister cartons of 100 (10 x 10) unit dose tablets
ETODOLAC Extended-Release Tablets USP, 500 mg are grey-colored, oval-shaped, beveled edged, film-coated tablets, debossed with "272" on one side and plain on other side and are supplied as follows: NDC 68382-272-14 in bottles of 60 tablets with child–resistant closure NDC 68382-272-01 in bottles of 100 tablets NDC 68382-272-05 in bottles of 500 tablets NDC 68382-272-10 in bottles of 1,000 tablets NDC 68382-272-77 in unit-dose blister cartons of 100 (10 x 10) unit dose tablets
ETODOLAC Extended-Release Tablets USP, 600 mg are blue-colored, oval-shaped, beveled edged, film-coated tablets, debossed with "273" on one side and plain on other side and are supplied as follows: NDC 68382-273-14 in bottles of 60 tablets with child–resistant closure NDC 68382-273-01 in bottles of 100 tablets NDC 68382-273-05 in bottles of 500 tablets NDC 68382-273-10 in bottles of 1,000 tablets NDC 68382-273-77 in unit-dose blister cartons of 100 (10 x 10) unit dose tablets Storage: Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. Protect from excessive heat and humidity. Dispense in a tight, light-resistant container with a child-resistant closure. Medication Guide available at www.zydususa.com/medguides or call 1-877-993-8779.
More pills like OVAL 271